Because BETi-treated liver cancer cells can maintain energy homeostasis involving enhanced glutamine oxidative metabolism and anaplerosis for TCA cycle, we finally hypothesized that targeting OXPHOS would disrupt the energy balance and sensitize the cancer cells to BET inhibition. Here, DNER is linked to liver cancer.